Logo
x

Search

Subscribe Now

All Posts by Date

Samsung Bioepis’s SB12, a Proposed Biosimilar to Soliris (eculizumab) Meet its 1EPs in P-I Study for Paroxysmal Nocturnal Haemoglobinuria

Samsung Bioepis’s SB12, a Proposed Biosimilar to Soliris (eculizumab) Meet its 1EPs in P-I Study for Paroxysmal Nocturnal Haemoglo...

  • December 11, 2021
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.